Know Your ABCs: Discovery, Differentiation, and Targeting of T-Bet+ B Cells

Area of Science:

• Immunology
• Cell Biology
• Autoimmunity

Background:

• T-bet+ B cells, now known as Age-associated B Cells (ABCs), were first described in 2008.
• These cells are uniquely defined by their expression of the transcription factor T-bet.
• ABCs are involved in various immunological responses, including bacterial infections and autoimmunity.

Purpose of the Study:

• To review the discovery and diverse roles of T-bet+ B cells (ABCs).
• To highlight the role of T-bet in IgG2a class switching and its implications in immunity and autoimmunity.
• To explore the therapeutic potential of targeting ABCs for autoimmune diseases.

Main Methods:

• Review of existing literature on T-bet+ B cells (ABCs).
• Analysis of T-bet's role in B cell class switching.
• In vivo studies using adenosine 2a receptor (A2aR) agonists to target ABCs.

Main Results:

• T-bet+ ABCs are critical in T cell-independent and T cell-dependent B cell responses.
• T-bet plays a limited but crucial role in IgG2a class switching.
• A2aR agonist administration effectively targeted ABCs in vivo and reduced disease symptoms in lupus-prone mice.

Conclusions:

• T-bet+ ABCs are a significant B cell subset with implications in both immunity and autoimmunity.
• Pharmacological targeting of ABCs, particularly via A2aR agonists, presents a potential therapeutic strategy for autoimmune diseases.